Kundan Singh Chufal
Overview
Explore the profile of Kundan Singh Chufal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dewan A, Kumar L, Chufal K, Bhushan M, Ahmad I, Barik S, et al.
Asian Pac J Cancer Prev
. 2025 Mar;
26(2):631-638.
PMID: 40022711
Objective: To analyse the dosimetric benefit achieved with Deep inspiratory breath hold (DIBH) for left sided breast irradiation and to identify the factors impacting it. Methods: Between 1st January'2023 to...
2.
Chufal K, Ahmad I, Miller A, Bajpai R, Dwivedi A, Dwivedi A, et al.
Radiother Oncol
. 2025 Feb;
205:110764.
PMID: 39894262
Objective: Multi-day assessments accurately identify patients with left-sided breast cancer who are ineligible for irradiation in Deep Inspiration Breath Hold (DIBH) and minimise on-couch treatment time in those who are...
3.
Ahmad I, Chufal K, Miller A, Bajpai R, Umesh P, Sokhal B, et al.
Radiat Oncol
. 2024 Aug;
19(1):115.
PMID: 39210454
Objective: To identify variables associated with a patients' ability to reproducibly hold their breath for deep-inspiration breath-hold (DIBH) radiotherapy (RT) and to develop a predictive model for DIBH eligibility. Methods:...
4.
Ahmad I, Chufal K, Miller A, Bajpai R, Umesh P, Dawer A, et al.
Br J Radiol
. 2024 Mar;
97(1157):913-919.
PMID: 38538948
Oligometastatic non-small cell lung cancer (OMD NSCLC) has been proposed to bridge the spectrum between non-metastatic and widely metastatic states and is perceived as an opportunity for potential cure if...
5.
Lal Chowdhary R, Chufal K, Ismail M, Ahmad I, Jwala M, Pahuja A, et al.
Rep Pract Oncol Radiother
. 2023 Oct;
28(4):454-462.
PMID: 37795230
Background: The aim was perusal of the treatment strategies, clinical outcomes and factors impacting these outcomes in thymoma. Materials And Methods: A total of 119 patients diagnosed and treated cases...
6.
Ahmad I, Chufal K, Bajpai R, Lal Chowdhary R
Int J Radiat Oncol Biol Phys
. 2023 Aug;
117(1):286-287.
PMID: 37574242
No abstract available.
7.
Ahmad I, Chufal K, Miller A, Bajpai R, Lal Chowdhary R, Sharief M, et al.
Pract Radiat Oncol
. 2023 Feb;
13(2):e115-e120.
PMID: 36748210
The advent of computed tomography-based planning coupled with modern tools for target delineation and hypofractionated treatment schedules has increased efficiency and throughput for patients with breast cancer. While the benefit...
8.
Chufal K, Ahmad I, Bajpai R, Miller A, Lal Chowdhary R, Makker J, et al.
Br J Radiol
. 2022 Dec;
96(1143):20220413.
PMID: 36541255
Objective: To evaluate treatment outcomes in patients from a low-middle income country (LMIC) with esophageal carcinoma who underwent esophagectomy after neoadjuvant chemoradiation (NACRT/S). Methods: Between 2010 and 2020, 254 patients...
9.
Mitra S, Simson D, Khurana H, Tandon S, Ahlawat P, Bansal N, et al.
Asian Pac J Cancer Prev
. 2022 Jul;
23(7):2415-2420.
PMID: 35901349
Purpose: To analyze the impact of treatment delay caused by COVID-19 infection on patients scheduled for radiotherapy treatment. Methods And Materials: In this descriptive study, we analyzed all patients who...
10.
Batra U, Chufal K, Nathany S, Ahmad I, Lal Chowdhary R, Sharma M, et al.
Immunotherapy
. 2022 Jun;
14(11):851-858.
PMID: 35698820
To analyze the outcomes of patients receiving immunotherapy (IO) with advanced non-driver mutated non-small-cell lung cancer (NSCLC) after progression on systemic treatment. The overall survival (OS), progression-free survival (PFS) and...